Access Bio Dividends and Buybacks
Dividend criteria checks 2/6
Access Bio is a dividend paying company with a current yield of 14.78%.
Key information
14.8%
Dividend yield
-0.2%
Buyback Yield
| Total Shareholder Yield | 14.5% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₩823.000 |
| Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Access Bio, Inc.'s (KOSDAQ:950130) Prospects Need A Boost To Lift Shares
Nov 13
Optimistic Investors Push Access Bio, Inc. (KOSDAQ:950130) Shares Up 38% But Growth Is Lacking
Aug 07Access Bio's (KOSDAQ:950130) Earnings Are Weaker Than They Seem
Mar 26Is Access Bio (KOSDAQ:950130) A Risky Investment?
Mar 25If You Had Bought Access Bio (KOSDAQ:950130) Shares A Year Ago You'd Have Earned 740% Returns
Feb 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A950130 has been paying a dividend for less than 10 years.
Growing Dividend: A950130 has only been paying a dividend for 2 years, and since then payments have not increased.
Dividend Yield vs Market
| Access Bio Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A950130) | 14.8% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Medical Equipment) | 1.8% |
| Analyst forecast (A950130) (up to 3 years) | n/a |
Notable Dividend: A950130's dividend (14.78%) is higher than the bottom 25% of dividend payers in the KR market (1.24%).
High Dividend: A950130's dividend (14.78%) is in the top 25% of dividend payers in the KR market (3.93%)
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A950130's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: A950130 is paying a dividend but the company has no free cash flows.